一、概况——八十年代抗生素品种动态抗生素类药物在世界医学临床上是一类不可缺少的药物。因此,在很多国家的医药工业中的产值居于首位。(如日本1982年医药总产值达165.86亿美元,比1981年增加了7.3%。抗生素类药物居于首位)。资本主义国家不惜巨额资金进行抗生素新品种的研究和发展。在销售市场上展开了激烈的斗争。一九八一年世界主要医药公司的抗生素产值达85亿美元(预计2000年可达到335亿美元)。八十年代初世界上生产的抗生素达10万吨以上(包括非医用的抗生素)。世界主要资本主义国家生产的医用抗生素约为25,000 First, an overview - the eighties antibiotic varieties Dynamic antibiotics in the world of clinical medicine is an indispensable class of drugs. Therefore, the output value of the pharmaceutical industry in many countries ranks first. (For example, Japan’s total pharmaceutical output reached US $ 16.586 billion in 1982, an increase of 7.3% over 1981. Antibiotics tops the list.) Capitalist countries at huge amounts of funds for new antibiotic research and development. In the sales market launched a fierce battle. In 1981, the world’s major pharmaceutical companies produced 8.5 billion U.S. dollars of antibiotics (estimated to reach 33.5 billion U.S. dollars in 2000). In the early 1980s, the world produced more than 100,000 tons of antibiotics (including non-medical antibiotics). The world’s major capitalist countries produce about 25,000 medical antibiotics